Great Point Partners as of March 31, 2014
Portfolio Holdings for Great Point Partners
Great Point Partners holds 34 positions in its portfolio as reported in the March 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Furiex Pharmaceuticals | 9.3 | $18M | 206k | 87.00 | |
Orthofix International Nv Com Stk | 8.1 | $16M | 515k | 30.15 | |
Hyperion Therapeutics | 6.7 | $13M | 494k | 25.80 | |
Pain Therapeutics | 6.6 | $13M | 2.3M | 5.50 | |
Alimera Sciences | 6.2 | $12M | 1.5M | 7.89 | |
Derma Sciences | 6.1 | $12M | 925k | 12.68 | |
Oxygenbiotherapeutics Inccom Par | 5.8 | $11M | 2.0M | 5.55 | |
Neurocrine Biosciences (NBIX) | 5.2 | $10M | 620k | 16.10 | |
Ambit Bioscience | 3.4 | $6.6M | 719k | 9.12 | |
Infinity Pharmaceuticals (INFIQ) | 3.1 | $5.9M | 500k | 11.89 | |
Volcano Corporation | 3.1 | $5.9M | 300k | 19.71 | |
Alcobra | 2.8 | $5.3M | 294k | 18.15 | |
Veracyte (VCYT) | 2.8 | $5.3M | 310k | 17.13 | |
Sophiris Bio | 2.6 | $5.0M | 1.5M | 3.33 | |
Anthera Pharmaceutcls | 2.4 | $4.6M | 1.4M | 3.35 | |
MannKind Corporation | 2.2 | $4.3M | 1.1M | 4.02 | |
AVEO Pharmaceuticals | 2.2 | $4.3M | 2.9M | 1.49 | |
Sunshine Heart | 2.2 | $4.2M | 727k | 5.84 | |
Recro Pharma (SCTL) | 2.2 | $4.2M | 580k | 7.32 | |
Protalix BioTherapeutics | 2.2 | $4.2M | 912k | 4.58 | |
Cara Therapeutics (CARA) | 1.7 | $3.3M | 178k | 18.61 | |
Ocera Therapeutics | 1.7 | $3.3M | 312k | 10.55 | |
Cytokinetics (CYTK) | 1.6 | $3.0M | 315k | 9.50 | |
Oncothyreon | 1.6 | $3.0M | 992k | 2.99 | |
Nanosphere | 1.4 | $2.8M | 1.3M | 2.15 | |
Dipexium Pharmaceuticals | 1.3 | $2.5M | 250k | 10.08 | |
Mei Pharma | 0.9 | $1.8M | 158k | 11.13 | |
Chemocentryx | 0.9 | $1.7M | 250k | 6.63 | |
OncoGenex Pharmaceuticals | 0.8 | $1.5M | 130k | 11.76 | |
Kalobios Pharmaceuticals | 0.8 | $1.5M | 537k | 2.71 | |
Sunesis Pharmaceuticals | 0.7 | $1.3M | 194k | 6.61 | |
pSivida | 0.6 | $1.2M | 283k | 4.10 | |
Streamline Health Solutions (STRM) | 0.4 | $763k | 152k | 5.03 | |
Momenta Pharmaceuticals | 0.4 | $722k | 62k | 11.65 |